Metachronous lung metastases of mammary carcinoma, or dual malignancy? A surgeon’s and oncologist’s point of view − case report

Česká verzia

Authors: M. Benej ¹; H. Čoupková ²; I. Čapov ¹; S. Haruštiak ³; J. Wechsler ¹; J. Halámková ²
Authors place of work: I. chirurgická klinika LF MU a FN u sv. Anny v Brně, přednosta: prof. MUDr. I. Čapov, CSc. ¹; Klinika komplexní onkologické péče, MOÚ, ředitel: prof. MUDr. J. Vorlíček, CSc., Dr. h. c. ²; Klinika hrudníkovej chirurgie FNsPBA – Ružinov, Bratislava, SR, přednosta: prof. MUDr. S. Haruštiak, CSc. ³
Published in the journal: Rozhl. Chir., 2014, roč. 93, č. 10, s. 516-519.
Category: Kazuistika

Summary

Synchronous and metachronous metastases significantly diminish the possibility of remission from cancer. Therefore, therapy needs to be highly effective and strictly individualised. The authors present a case report of a female patient after radical mastectomy due to breast cancer with incidental detection of peripheral lung carcinoid. The aim of the case report is to inform about current trends in primary lung carcinoid therapy through a surgeon’s and oncologist’s point of view.

Keywords:
breast carcinoma – metastasectomy − lung carcinoid − surgical and oncological therapy

Zdroje

1. Alper T, Zusuf B. Bronchial sleeve resections for carcinoid tumor in the first decade of life: Interactive Cardiovascular and Thoracic Surgery 2004;3:280−282.

2. Arrigoni MG, Woolner LB. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 1972;64:413−421.

3. Bajetta E, et al. 5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors. Cancer 1998;83:372−378.

4. Bini A, Brandolini J, Cassanelli N. Typical and atypical pulmonary carcinoids: our institutional experience. Interact Cardio Vasc Thorac Surg 2008;7:415−418.

5. Cardillo G, Sera F, Martino Di. Bronchial carcinoid tumors: nodal status and long term survival after resection. Ann Thorac Surg 2004;77:1781−1788.

6. Čapov I, a spol. Chirurgie orgánových metastáz. Praha, Galén 2008:181.

7. Detterbeck F, Puchalski J, Rubinowitz A, Cheng D. Classification of the Thoroughness of Mediastinal Staging of Lung cancer. Chest 2010;137:436−442.

8. Dundr P, Hornychová H, Matěj R, Ryška A, Staněk L, a spol. Doporučený postup pro histologické vyšetření karcinomu plic. Společnost českých patologů, ČLS JEP 2013.

9. Granberg D, Eriksson B, Wilander E. Experience in treatment of metastatic pulmonary carcinoid tumors. Ann Oncol 2001;12:1383−1391.

10.. Hage R, Brutel de la Riviere A, Seldenrijk C, et al. Update in pulmonary carcinoid tumors: A review article. Annals of Surgical Oncology 2003;10:697−704

11. Hornbech K, Ravn J, Steinbruechel DA. Current Status of Pulmonary Metastasectomy. Eur J Cardiothorac Surg 2011;39: 955−962.

12. Internullo E, Cassivi SD, Van Raemdonck D, et al. Pulmonary Metastasectomy. J Thorac Oncol 2008;3:1257−1266.

13. Jaklitsch MT, Mery CM, Lukanich JM, et al. Sequential Thoracic Metastasectomy Prolongs Survival by Re-establishing Local Control Within the Chest. J Thorac Cardiovasc Surg 2001;121:657−667.

14. Janík M, Lučenič M, Krajč T, Benej R, Haruštiak S. Karcinoid pľúc z pohľadu torakochirurga. Respiro 2008;4:26−31.

15. Mehran RJ, Deslauriers J. Survival related to nodal status after sleeve resection for lun cancer. J Thorac Cardiovasc Surg 1994;107:576−583.

16. Mountain CF, McMurtrey MJ, Hermes KE. Surgery for Pulmonary Metastasis: A 20-Year Experience. Ann Thorac Surg 1984;38:323−330.

17. Öberg K, et al. Cytotoxic treatment in patients with malignant carcinoid tumors. Response to streptozotocin – alone or in combination with 5-FU. Acta Oncol 1987;26:429−432.

18. Öberg K, et al. Neuroendocrine Bronchial and Thymic Tumours: ESMO Clinical Practice Guidelines. Ann Oncol 2012;23 (Suppl 7):120−123.

19. Pastorino U, Buyse M, Friedel G, et al. Long-Term Results of Lung metastasectomy: Prognostic Analyses Based on 5206 Cases. J Thorac Cardiovasc Surg 1997;113:37−49.

20. Pastorino U, Grunenwald D. Surgical Resection of Pulmonary Metastase: Pearson´s Thoracic and Esophageal Surgery. Third Edition, Churchill Livinstone 2008;1795.

21. Pelosi G, Rodriguez J, Viale G, et al. Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens. American Journal of surgical pathology 2005;29:179−187.

22. Pfannschmidt J, Klode J, Muley T, et al. Nodal Involment at the Time of Pulmonary Metastasectomy. Ann Thorac Surg 2006; 81: 448−454.

23. Pfannschmidt J, Muley T, Hoffmann H, Dienemann H. Prognostic Factors and Survival after Complete Resection of Pulmonary Metastases from Colorectal Carcinoma: Experiences in 167 Patients. J Thorac Cardiovasc Surg 2003;126:732−739.

24. Rea F, Rizzardi G, Zurin A, et al. Outcome and surgical strategy in bronchial carcinoid tumors: single institution experience with 252 patients. European Journal of Cardio-thoracic Surgery 2007;31:186−191.

25. Robert JH, Ambrogi V, Mermillod B, et al. Factors Influencing Long-term Survival After Lung Metastasectomy: Ann Thorac Surg 1997;63:777−784.

26. Schützner J, Pafko P, Stolz, A. Rakovina plic − zlepšila se operabilita a prognóza? Praktický lékař 2000;80:533−534.

27. Swensen S, Jett J, Sloan J, et al. Screening for lung cancer with low-dose spiral computed tomography. American journal of respiratory and critical care medicine 2002;165:508−513.

28. Travis WD, Brambilla E, Riely GJ. New Pathologic Classification of Lung Cancer: Relevance for clinical Practice and Clinical Trials. J Clin Oncol 2013; 31:992−1001.

29. Van Schil PE, Schepens MA. Late results of sleeve resection for typical bronchial carcinoid:. Eur J Cardiothor Surg 1994;8:118−21.